Every drying guide for these mushrooms was written for Amanita muscaria, and the advice gets copied onto Amanita pantherina without anyone checking whether it applies. In the one published market analysis that measured both species side by side, it doesn't. The pantherina caps arrived already muscimol-dominant — the state muscaria drying is supposed to produce. Drying them harder isn't converting a precursor. It's concentrating a finished agonist in the species that already had more of it.
Tsujikawa's 2006 analysis in Forensic Science International measured seven market mushrooms by GC-MS. The two Amanita pantherina caps contained 1,554–1,880 ppm muscimol against only 188–269 ppm ibotenic acid — muscimol-dominant by roughly six- to tenfold. The five Amanita muscaria caps ranged from 46 to 1,052 ppm muscimol with ibotenic acid up to 2,845 ppm, so some were the opposite way round. Muscarine, meanwhile, is thermostable: no drying schedule removes it. And all four commercial "Amanita extract" products in the same study contained no detectable muscimol at all — but did contain tropane alkaloids and tryptamines.
Two caps is a small sample, and market material has an unknown processing history. Both caveats matter, and both are discussed below rather than buried.
What Does Drying Actually Do to These Mushrooms?
It decarboxylates ibotenic acid into muscimol. Ibotenic acid acts on glutamate receptors and is the compound most associated with nausea and the agitated, disoriented phase. Muscimol is a GABA-A agonist and drives the sedative side. Losing a carboxyl group under heat converts one into the other, which is why "dry it properly" became the standard advice.
That logic is sound for Amanita muscaria, and our chemistry article and muscaria drying guide lay it out. The question nobody asks is what happens when you apply it to a mushroom that starts from a different place.
Where Does Pantherina Actually Start?
Much further along the conversion than muscaria does. Tsujikawa's team analysed seven mushrooms sold in Japan as one species or the other — five muscaria, two pantherina — extracting with 70% methanol and quantifying by gas chromatography–mass spectrometry.
The two pantherina caps came in at 188–269 ppm ibotenic acid and 1,554–1,880 ppm muscimol. The five muscaria caps spanned under 10 to 2,845 ppm ibotenic acid and 46 to 1,052 ppm muscimol.
Read those two rows against each other. Both pantherina samples carried more muscimol than any of the muscaria samples, and carried it alongside comparatively little ibotenic acid. On this data, pantherina isn't simply "stronger" — it's differently composed.
So Does the Muscaria Drying Protocol Even Make Sense Here?
Partly, and for a different reason than usually given. If a pantherina batch already sits at roughly six to ten times more muscimol than ibotenic acid, aggressive heat isn't rescuing you from an ibotenic acid problem — there isn't much left to convert.
What heat does instead is finish the small remaining conversion and drive off water, concentrating everything by weight. On a material that already outstripped every muscaria sample in the study for muscimol, that's a potency question rather than a safety improvement.
The honest version of the advice: dry pantherina to preserve it and to stabilise it, not to detoxify it. Storage rules are the same as for muscaria and covered in our storage guide.
What Drying Cannot Do
Remove muscarine. Muscarine is thermostable and water-soluble, which is why poisonings from muscarine-rich genera like Inocybe and Clitocybe happen after cooking as readily as before it. Heat that decarboxylates ibotenic acid leaves muscarine chemically intact.
This matters because the cholinergic symptoms — sweating, salivation, watering eyes, gut cramping, slowed heart rate — are the ones people most often write off as "part of it". Feeney's 2025 work reopened the muscarine question for Amanita muscaria after decades of it being treated as settled, and pantherina has never had the equivalent survey done.
So drying improves one hazard and provably cannot touch the other. A well-dried batch is not a de-risked batch.
Why the Usual "Scale Down From Muscaria" Rule Is Weak
Because it treats the difference as a multiplier when the data suggests it's a different composition. The common heuristic — pantherina is two to three times muscaria, so use a fraction of the amount — comes from potency folklore, not from measured compound ratios.
A muscimol-dominant material behaves differently, not just more strongly: less of the early excitatory, nauseating phase and more of the sedative one, arriving on its own timeline. Our onset and duration article covers what that looks like, and the potency and risk guide covers why the variability itself is the hazard.
Caps, Stems and Which Part You're Drying
Tsujikawa found both compounds concentrated in the flesh of the cap rather than the cuticle, and stem contents far lower than cap contents. That has a practical consequence people rarely account for.
If a batch is cap-heavy, it's more potent per gram than a batch padded with stems — before drying enters the picture at all. Two correctly dried batches from the same forest can differ substantially on anatomy alone, which is why weighing by grams is a rough instrument.
| Variable | Effect on the final material | Under your control? |
|---|---|---|
| Species | Pantherina samples were muscimol-dominant; muscaria ranged either way | Yes — buy one and stay with it |
| Cap vs stem ratio | Caps far richer; flesh richer than cuticle | Partly, if you can see the material |
| Drying temperature and time | Converts remaining ibotenic acid; concentrates by weight | Yes, if you dry it yourself |
| Muscarine content | Unchanged by any drying schedule | No |
| Batch-to-batch variation | Large, and not visible on inspection | No — recalibrate every batch |
The Finding That Should Worry Extract Buyers
The same study analysed four commercial products described as "extracts purported to contain A. muscaria". Ibotenic acid and muscimol were below the limit of calibration or not detected at all.
What those products did contain was psychoactive tryptamines — 5-methoxy-N,N-diisopropyltryptamine and 5-methoxy-N,N-dimethyltryptamine — along with the reversible MAO inhibitors harmine and harmaline, and the tropane alkaloids atropine and scopolamine.
None of that is Amanita chemistry. Four out of four products sold as Amanita extract contained none of the compounds they were sold for, and several that could interact dangerously with each other. This is the strongest argument in the literature for buying whole dried caps you can look at, and it's why our extracts versus dried fruits article takes the position it does.
Practical Drying Guidance for Pantherina
- Dry low and slow, and dry completely. The goal is preservation and stability. Bone-dry material stores; leathery material grows mould.
- Don't chase a decarboxylation endpoint you may already be past. If your material is pantherina, the ibotenic acid fraction is likely small to begin with.
- Keep caps and stems separate if you're drying your own. They aren't the same material by weight.
- Label every batch with its date and source, because the batch is the unit of potency, not the species.
- Recalibrate from a low dose with every new batch, including one you dried yourself the same way as the last.
- Don't treat drying as detoxification. It isn't, and muscarine is the proof.
What This Data Can't Tell You
Quite a lot, and pretending otherwise would be the same error the muscaria-derived advice makes. Two pantherina samples is not a survey. The material came off a market with an unknown processing history, so some of the muscimol dominance may reflect drying that already happened rather than the fresh mushroom's composition.
No one has published a controlled drying experiment on Amanita pantherina measuring both compounds before and after at defined temperatures. Until someone does, the honest position is that the muscaria protocol has no demonstrated validity here — not that a better protocol is known.
Frequently Asked Questions
Do you need to decarboxylate Amanita pantherina?
Possibly less than muscaria. In the only side-by-side market analysis, pantherina caps carried 188–269 ppm ibotenic acid against 1,554–1,880 ppm muscimol — already muscimol-dominant. There may be little precursor left to convert, though the samples' processing history was unknown.
Does drying make Amanita pantherina safer?
Only partly. Drying converts ibotenic acid, which reduces the nauseating excitatory component. It does nothing to muscarine, which is thermostable and survives any drying schedule intact. A well-dried batch is a more predictable batch, not a de-risked one.
Is Amanita pantherina stronger than Amanita muscaria?
On the available measurements, both pantherina caps exceeded every muscaria cap for muscimol. But the difference is compositional, not a simple multiplier — pantherina was muscimol-dominant while some muscaria samples were the reverse, which changes the character of the effect and not only its size.
Are the caps stronger than the stems?
Yes, substantially. Tsujikawa found ibotenic acid and muscimol far lower in stems than caps, and more concentrated in cap flesh than in the cuticle. A cap-heavy batch is stronger per gram than a stem-padded one before any drying is considered.
Are Amanita extracts safer than dried caps?
The evidence points the other way. All four "Amanita extract" products in Tsujikawa's study contained no detectable muscimol, but did contain tryptamines, harmine, harmaline, atropine and scopolamine — none of which belong in Amanita.
Shop Amanita pantherina
We sell whole dried caps you can inspect, which is the point of the section above. Dried Amanita pantherina (50 g €85, 100 g €155) lets you see the cap-to-stem ratio you're paying for. Capsules (120 caps €79) remove weighing error, which matters more for this species than for muscaria. Powder (100 g €100) mixes easily but hides the anatomy. Read the contraindications first. Free shipping on orders over €50.
Related Articles
- Amanita pantherina Active Compounds
- Amanita pantherina Potency and Risk Guide
- Amanita pantherina Formats Compared
- Amanita pantherina vs Amanita muscaria
- Ibotenic Acid vs Muscimol
- How to Dry Amanita muscaria
- Amanita muscaria Side Effects and Interactions
Sources
- Tsujikawa K, Mohri H, Kuwayama K, et al. Analysis of hallucinogenic constituents in Amanita mushrooms circulated in Japan. Forensic Sci Int. 2006;164(2-3):172-178. PubMed 16464551
- Michelot D, Melendez-Howell LM. Amanita muscaria: chemistry, biology, toxicology, and ethnomycology. Mycol Res. 2003;107(2):131-146. PubMed 12747324
- Moss MJ, Hendrickson RG. Toxicity of muscimol and ibotenic acid containing mushrooms reported to a regional poison control center from 2002-2016. Clin Toxicol (Phila). 2019;57(2):99-103. PubMed 30073844
- Feeney K, Kababick J, Wise S. An examination of cholinergic symptoms produced by the fly agaric mushroom Amanita muscaria (Agaricomycetes): revisiting the role of muscarine. Int J Med Mushrooms. 2025;27(7):1-15. PubMed 40228215